Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Earley

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Kidney International|July 1, 2026
KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the futureBenjamin Lazarus, Laia Oliveras, Amara Sarwal, et al.
Kidney International|April 20, 2025
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in ChildrenJürgen Floege, Keisha L Gibson, Marina Vivarelli, et al.
Kidney International|May 13, 2024
Corrigendum to "Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis." Kidney International 2024;105(3):447-449Jürgen Floege, David R W Jayne, Jan-Stephan F Sanders, et al.
Kidney International|February 22, 2024
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated VasculitisJürgen Floege, David R W Jayne, Jan-Stephan F Sanders, et al.
Kidney International|May 26, 2026
The Kidney in the Middle: KDIGO Guidelines Address Multiple Key Components of Cardiovascular-Kidney-Metabolic SyndromeAdeera Levin, Nisha Bansal, Ian H de Boer, et al.
Kidney International|January 5, 2024
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus NephritisBrad H Rovin, Isabelle M Ayoub, Tak Mao Chan, et al.
Kidney International|September 20, 2025
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)Jürgen Floege, Jonathan Barratt, H Terence Cook, et al.
Kidney International|November 21, 2022
Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney DiseasePaul Martin, Ahmed A Awan, Marina C Berenguer, et al.
Kidney International|September 24, 2018
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and managementMichel Jadoul, Marina C Berenguer, Wahid Doss, et al.
Annals of Internal Medicine|December 11, 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice GuidelineAhmed Arslan Yousuf Awan, Marina C Berenguer, Annette Bruchfeld, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Kidney International|July 1, 2026
KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the futureBenjamin Lazarus, Laia Oliveras, Amara Sarwal, et al.
Kidney International|April 20, 2025
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in ChildrenJürgen Floege, Keisha L Gibson, Marina Vivarelli, et al.
Kidney International|May 13, 2024
Corrigendum to "Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis." Kidney International 2024;105(3):447-449Jürgen Floege, David R W Jayne, Jan-Stephan F Sanders, et al.
Kidney International|February 22, 2024
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated VasculitisJürgen Floege, David R W Jayne, Jan-Stephan F Sanders, et al.
Kidney International|May 26, 2026
The Kidney in the Middle: KDIGO Guidelines Address Multiple Key Components of Cardiovascular-Kidney-Metabolic SyndromeAdeera Levin, Nisha Bansal, Ian H de Boer, et al.
Kidney International|January 5, 2024
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus NephritisBrad H Rovin, Isabelle M Ayoub, Tak Mao Chan, et al.
Kidney International|September 20, 2025
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)Jürgen Floege, Jonathan Barratt, H Terence Cook, et al.
Kidney International|November 21, 2022
Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney DiseasePaul Martin, Ahmed A Awan, Marina C Berenguer, et al.
Kidney International|September 24, 2018
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and managementMichel Jadoul, Marina C Berenguer, Wahid Doss, et al.
Annals of Internal Medicine|December 11, 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice GuidelineAhmed Arslan Yousuf Awan, Marina C Berenguer, Annette Bruchfeld, et al.
Pageof 5